寿仙谷股票讨论区

Zhejiang Shouxiangu Pharmaceutical's low P/E ratio is due to its projected growth being less than the broader market. Investors foresee limited future growth and are only prepared to pay a lower price for the stock, suggesting the share price may not rise significantly soon.